TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT05356585

Circulating Tumor DNA to Monitor the Efficacy of Total Neoadjuvant Therapy for Rectal Cancer

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.
“Sponsor already published research that was to be obtained from this study.”

The sponsor’s own words in the registry.

Life of this trial

2022202320242025Registered2022-04-27Planned start2023-12-30 (planned)Withdrawn (as of)2024-04-12

Vital statistics

Status
Withdrawn
Sponsor
Case Comprehensive Cancer Center
Sponsor type
University, hospital or other
Conditions
Colorectal Cancer; Rectal Cancer
Interventions
SignateraTM assay
Participants
0
Sites
1
Countries
United States

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.